Microneedling Contraindications: A Professional Screening Guide

Microneedling contraindications are not a one-size-fits-all checklist. For professional practices, safe screening starts with a complete intake, a review of the exact device instructions, and a qualified clinician’s judgment about whether to proceed, pause, or refer. This guide outlines a workflow—not a diagnosis or patient-specific treatment advice.

Contact Emage Medical to discuss professional microneedling equipment

What Does “Contraindication” Mean in a Microneedling Practice?

A contraindication is a reason a treatment may not be appropriate in a particular situation. The term can refer to an absolute restriction in a specific device’s instructions or a factor that calls for additional assessment, a modified plan, postponement, or referral. These categories are not interchangeable. The correct interpretation depends on the device, the proposed procedure, the patient’s history and current condition, the treating professional’s scope, and applicable state rules.

That is why a generic online list should never replace the instructions for use (IFU) supplied with the selected device. Device labeling may specify warnings, precautions, and contraindications. Federal device regulations describe labeling elements that may include device-specific warnings and contraindications; review the actual labeling for the device being used rather than assuming that one model’s instructions apply to another. See 21 CFR Part 878.

Professional rules matter too. For example, Kentucky Board of Nursing guidance identifies client selection, history taking, physical assessment, indications, and contraindications as elements of cosmetic and dermatologic procedure practice. It is a state-specific reference, not a nationwide scope-of-practice rule; check the requirements that apply to your practice location. Review the Kentucky Board of Nursing guidance.

Published research can also illustrate why practices should review each study’s actual protocol instead of treating a paper as a universal screening standard. One open-label study of radiofrequency microneedling reports that its screening visit occurred two weeks before the procedure. That describes the study’s design, not a required interval for every practice or device. See the published RF microneedling study.

Which Intake Questions Should Practices Ask?

Use an intake process that gathers relevant information before the treatment date, then confirm that nothing material has changed at the appointment. The form should support a conversation with the qualified treating professional; it should not make an automated “clearance” decision. Ask questions in plain language, explain why the information is needed, and provide a way for the patient to discuss sensitive answers privately.

• Current skin condition: Ask about concerns in the intended treatment area, including irritation, wounds, infection, active inflammation, or a recent procedure. A clinician should assess the area and decide whether treatment is appropriate or should be delayed.
• Health history: Ask about relevant health conditions and changes in health. Do not assume that a patient’s own label or a checkbox alone tells you how it affects treatment.
• Medicines and topical products: Record prescription and nonprescription medicines, supplements, and products used on the treatment area. Ask about recent changes and route clinical questions to the treating professional.
• Healing and scarring history: Ask whether the patient has experienced unusual healing or raised scars, and whether they have concerns about healing. The answer is a prompt for professional assessment, not a stand-alone diagnosis.
• Bleeding, immune, and other relevant history: Ask questions consistent with the IFU and your clinician-approved intake protocol. Do not tell patients to stop or change a prescribed medicine; refer medication questions to the appropriate prescriber.
• Pregnancy, nursing, and other special circumstances: Include questions when required by the device instructions or your clinical protocol. If the answer raises uncertainty, pause and obtain qualified guidance rather than making an assumption.
• Previous treatments and expectations: Document prior procedures in the area, approximate timing, and the patient’s goals. Clarify that eligibility and expected outcomes require an individual assessment.

These are screening prompts, not a universal or exhaustive list of contraindications. The clinical team should determine which questions belong in its protocol based on applicable labeling, professional standards, local requirements, and the procedures actually offered. Practices planning to launch a service can also review this guide to adding professional microneedling services as a practice-planning resource.

Make the intake usable as well as complete. Group questions into clear sections, leave room for a patient to explain a “yes” answer, and identify who will review responses. Avoid wording that implies a positive answer automatically disqualifies someone or that a negative answer guarantees eligibility. For example, “List any recent changes to medicines or skin products” invites context that a simple yes/no item can miss. The clinician can then decide whether the detail is relevant under the IFU and practice protocol.

Set a process for updates. A form completed well before the appointment is a starting point, not a substitute for confirmation on the day. Ask the patient to report changes since completing it, and make the update visible to the professional making the decision. If an answer is missing or hard to interpret, note the exact question that needs follow-up instead of silently treating a blank as “no.”

Which Findings Call for a Pause or Escalation?

When an intake answer or the day-of assessment raises a concern, avoid treating through uncertainty. The next step may be a clinician’s further assessment, a request for additional information, a postponement, or referral to another qualified professional. Do not use an article or a form to determine a patient’s diagnosis or make a treatment decision outside your scope.

Screening finding	Practice response	What to document
Possible active skin issue or injury in the planned area	Pause and have the treating clinician assess whether to proceed, postpone, or refer.	Patient’s report, observed concern, clinician assessment, and decision.
Relevant health condition, medication, or recent change	Compare with the device IFU and protocol; obtain clinician or prescriber input when needed.	Information collected, source of guidance, and follow-up plan.
History that may affect healing or scarring	Escalate for qualified review; do not infer eligibility from a checkbox.	Relevant history, discussion, and rationale for the decision.
Unclear answer, missing history, or conflicting information	Do not proceed until the responsible professional resolves the uncertainty.	What remains unclear, who will follow up, and any scheduling decision.
Concern outside the practice’s scope or expertise	Refer the patient to an appropriate licensed professional and defer treatment.	Reason for referral and communication, consistent with privacy policies.

This table is a workflow aid, not a substitute for the device’s contraindications or a clinical protocol. A finding may mean different things depending on the patient, device, procedure, and jurisdiction. The responsible clinician should make and record the decision.

Escalation works best when the team agrees on what happens next. Assign a named role—not just “the office”—to review flagged answers, set a reasonable follow-up process, and communicate the outcome to scheduling staff. For example, if a patient reports a recent change but the intake does not explain it, staff can mark the item for clinician review and hold the treatment appointment as appropriate under office policy. They should not guess at significance or tell the patient what the answer means medically.

Also distinguish administrative decisions from clinical ones. A staff member may identify a missing form or route a question, while the qualified professional evaluates clinical relevance. A patient may need a separate consultation, more information, a later visit, or outside guidance. Use neutral language when explaining a pause: the practice is completing its review, rather than declaring the patient unsuitable or promising treatment after a set period.

How Should Practices Review Device Instructions?

Keep the current IFU accessible to everyone involved in screening and treatment. Before introducing a device or changing a protocol, identify the sections that address intended use, patient selection, warnings, precautions, contraindications, operation, cleaning, and required training. If the labeling is unclear, contact the manufacturer or distributor for clarification. Do not fill gaps with assumptions or copy instructions from an unrelated device.

1. Confirm the exact device and configuration. Check the model, handpiece or accessory, and any settings or components covered by its instructions.
2. Translate labeling into a review checklist. Preserve the meaning of each warning and restriction. Have the qualified clinical lead approve how those points are reflected in intake and day-of screening.
3. Define responsibility. Decide who collects the history, who reviews it, who performs the assessment, and who may authorize proceeding or postponing treatment.
4. Train the team. Staff should know how to flag an answer, who to notify, and how to avoid giving medical advice beyond their role.
5. Recheck when things change. Review updated labeling, changes in state requirements, and protocol revisions. Document staff training and the version of the protocol in use.

Make the review traceable. Record the device name and model, the IFU revision or date if provided, the protocol version, and the staff member responsible for checking them. When the manufacturer provides an update or clarification, determine whether intake questions, staff instructions, or consent materials need revision. Retire old forms from shared folders and printed stations so staff do not accidentally use conflicting versions.

Device type can matter. Traditional microneedling and radiofrequency microneedling are not interchangeable procedures, and instructions for one should not be assumed to govern the other. Practices comparing approaches can read about RF microneedling versus traditional microneedling, then consult the labeling for the specific device under consideration. For broader equipment considerations, see this RF microneedling machine guide for aesthetic practices.

What Should Informed Consent and Documentation Include?

Consent is a communication process, not just a signature. Explain the proposed procedure in terms the patient can understand, discuss material risks and alternatives as appropriate to the clinician’s role, answer questions, and allow time for the patient to decide. Follow the practice’s approved consent process and applicable rules. Do not promise a result or imply that a screening form guarantees safety.

A useful record is factual, dated, and attributable to the person who collected or reviewed the information. It may include:

• The completed intake and any relevant updates confirmed on the day of treatment.
• The area and procedure being considered, along with the device and applicable IFU version.
• Assessment findings and any concerns raised by the patient or staff.
• Questions referred to the clinician, prescriber, manufacturer, or another professional, and the guidance received.
• The decision to proceed, defer, or refer, including who made it and the reason.
• Consent discussions, patient questions, and the patient’s decision, consistent with recordkeeping and privacy requirements.

Keep documentation neutral. Record what the patient reports and what the professional observes without turning either into an unsupported diagnosis. If the patient is deferred, give a clear next step that stays within the practice’s scope. A related microneedling documentation guide can help practices think through consistent records and photography workflows.

Clear notes also help another authorized team member understand what remains unresolved. Instead of writing “not cleared,” identify the reported information, who reviewed it, what additional guidance is needed, and whether the appointment is being rescheduled or held pending follow-up. Avoid recording speculative conclusions. Follow the practice’s privacy and retention policies, and limit access to information to appropriate personnel.

How Can a Practice Build a Repeatable Screening Workflow?

A consistent workflow helps the team notice unanswered questions before the treatment room, rather than trying to resolve them under time pressure. Practices can adapt these steps with their clinical lead:

1. Before scheduling: Share basic eligibility and consultation expectations without making a promise that a patient is eligible. Collect initial information using an approved, privacy-conscious process.
2. Before the visit: Review forms for blank, unclear, or potentially relevant answers. Route clinical questions to the person designated by the practice.
3. At the visit: Confirm current information, discuss the proposed procedure, and have the qualified professional complete the assessment.
4. Before treatment: Verify that the decision is documented, consent is complete, and the team is following the correct device instructions and protocol.
5. If new information appears: Stop and reassess. Do not let a prior appointment, payment, or schedule pressure substitute for a fresh decision.
6. Afterward: Record the procedure and follow the device instructions and clinician-approved aftercare process. Provide a route for the patient to contact the practice with concerns.

Consider a simple handoff example. A coordinator receives an intake before the consultation and sees a blank response in a section the practice’s protocol requires. The coordinator does not fill in the answer or decide that the patient is eligible. They contact the patient through the practice’s approved process, flag the record for the designated reviewer, and confirm that the reviewer sees the update before treatment is considered. If the information remains incomplete, the team follows its defer-and-follow-up process.

A second checkpoint applies when circumstances change after the consultation. If the patient reports a new concern on the appointment day, staff should route it for review even if the earlier form and appointment notes looked complete. The practice should make it easy to pause the planned procedure, record the updated information, and tell the patient what the next step is. This avoids letting the schedule or prior discussion become an informal substitute for a current assessment.

Review the workflow periodically with the clinical lead and the staff who use it. Ask where forms routinely create confusion, whether escalation reaches the right person, and whether decisions are documented clearly. A practice considering a microneedling platform can also explore professional microneedling equipment considerations and compare them with its scope, protocols, training needs, and device-specific labeling.

Frequently Asked Questions

Is there one universal list of microneedling contraindications?

No. Screening should follow the exact device labeling, the planned procedure, qualified clinical judgment, professional scope, and applicable rules. General lists can be useful prompts, but they should not replace the IFU or individualized assessment.

Should a practice proceed if an intake answer is unclear?

Do not treat uncertainty as clearance. Route the question to the responsible qualified professional and resolve it before proceeding. Depending on the situation, the appropriate next step may be further review, postponement, or referral.

Can staff tell a patient to stop a medication before microneedling?

Staff should not advise patients to stop or change prescribed medication unless that direction is within their professional role and provided by the appropriate prescriber. Record the question and refer it to the treating clinician or prescriber for guidance.

Does a signed consent form confirm that treatment is appropriate?

No. Consent documents a discussion and the patient’s decision; it does not replace screening, clinical assessment, device instructions, or professional requirements. The practice should document both the consent process and the eligibility decision.

Where should a practice start when purchasing a device?

Review the intended use and full instructions for the exact device, confirm that the planned use fits the practice’s credentials and local requirements, and establish a clinician-approved screening and escalation protocol before offering treatment.

Speak with Emage Medical about professional microneedling equipment

Microneedling screening is strongest when it combines careful intake, device-specific instructions, qualified clinical review, and clear documentation. When a question cannot be resolved within the practice’s scope, pause and seek appropriate guidance before proceeding.